StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 
 
 
Immunome
23.61
+1.55%
 

IMNM

 

Immunome

$ 23.61

 
+$0.36 | +1.55%
 
 
Open
$ 23.29
 
 
MKT CAP
$ 1.26B
 
High
$ 24.16
 
 
VOL
$ 436.27K
 
Low
$ 22.75
 
 
AVG VOL
$ 0.85M
 
 
 

IMNM Stock Analysis

  Login to display Immunome (IMNM) recommendation from the last 90 days from financial news and social media.
 
 

IMNM Total Score

 

Chart

 
 

11.95

8

8.38

4.54

 
 
1month
3month
6month
1year
 
Total Return
IMNM
vs.
S&P500
 

 
1-week Return
+4.84%
 
+1.17%
 
 
5-week Return
+75.15%
 
+6.44%
 
 
10-week Return
+222.10%
 
+10.09%
 
 
 
 

Strengths

IMNM Rewards

 Outperform the market

IMNM Rewards

 Upgraded on attractively valued

IMNM Rewards

 Earnings are forecast to grow

 
 

IMNM Risk Level

This Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
IMNM Risk Level
LOW
HIGH

Risk Volatility

 

IMNM has Extreme Risk Level

Click here to check what is your level of risk

 

IMNM Analysts Opinion

The company overall standing based on key factors, offering insights into analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 

IMNM Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 

IMNM Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

3.40
 
 

Future

×
 

Future

4.50
 

IMNM Future Sentiment

 Outperform the market

IMNM Future Sentiment

 Earnings are forecast to grow

 
 

IMNM Analysts Opinion

IMNM Analysts opinion is negative and it remained unchanged from the past 3 months

 

IMNM Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
85%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
100%
100%
 
On Track
On Track
On Track
 

IMNM Street Opinion 

IMNM Street view is extremely ish and have positive views on the near-term outlook

 

IMNM Performance Sentiment

Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
85%
15%
Positive
Negative
11 out of 13
events present
2 out of 13
events present
 
 
Highlights
Last Modify
Price
% Change

 
Agreements
2 Weeks Ago
24.92
+7.83%
 
Agreements
2 Month Ago
12.00
+7.91%
 
HR Activity
2 Month Ago
11.54
-2.29%
 
 

IMNM Latest News Feed










 
 
 
joker
 
 
 
StocksRunner

Explore our IMNM Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our IMNM Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

IMNM Rewards

 Outperform the market

IMNM Rewards

 Upgraded on attractively valued

IMNM Rewards

 Earnings are forecast to grow

 
 
 

IMNM Risk Level

 
 
 

The Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
IMNM Risk Level
LOW
HIGH

Risk Volatility

 

IMNM has Extreme Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

IMNM

 

Immunome

$ 23.61

 
+$0.36 | +1.55%
 
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 23.29
 
 
MKT CAP
$ 1.26B
 
High
$ 24.16
 
 
VOL
$ 436.27K
 
Low
$ 22.75
 
 
AVG VOL
$ 0.85M
 
 
 

IMNM Analysis

  Sign in to view Immunome (IMNM) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

11.95

8

8.38

4.54

 
 
1month
3month
6month
1year
 
Total Return
IMNM
vs.
S&P500
 

 
1-week Return
+4.84%
 
+1.17%
 
 
5-week Return
+75.15%
 
+6.44%
 
 
10-week Return
+222.10%
 
+10.09%
 
 
 

IMNM Analysts Opinion

Overall standing by considering key factors, reflecting analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 

IMNM Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

4.00
 

IMNM Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

3.40
 
 

Future

×
 

Future

4.50
 

IMNM Future Sentiment

 Outperform the market

IMNM Future Sentiment

 Earnings are forecast to grow

 
 

IMNM Analysts Opinion

IMNM Analysts opinion is negative and it remained unchanged from the past 3 months

 

IMNM Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
85%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
100%
100%
 
On Track
On Track
On Track
 

IMNM Street Opinion 

IMNM Street view is extremely ish and have positive views on the near-term outlook

 
IMNM Performance Sentiment
Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
85%
15%
Positive
Negative
11 out of 13
events present
2 out of 13
events present
 

 
Highlights
Last Modify
Price
% Change

 
Agreements
2 Weeks Ago
24.92
+7.83%
 
Agreements
2 Month Ago
12.00
+7.91%
 
HR Activity
2 Month Ago
11.54
-2.29%
 
 
IMNM Latest News Feed

Immunome (IMNM) Price Target Increased by 179.17% to 34.17. The average one-year price target for Immunome (NasdaqCM:IMNM) has been revised to 34.17 / share. This is an increase of 179.17% from the prior estimate of 12.24 dat

Sat Feb 24, 2024

Potential

Immunome completes $230 million stock offering.

Fri Feb 16, 2024

Activity

Immunome Prices Public Offering Of 10 Mln Shares At $20/Shr. (RTTNews) - Immunome Inc. (IMNM) a biotechnology company announced that it has priced public offering of 10 million shares of common stock at $20.00 per share. The company expects offe

Wed Feb 14, 2024

Activity

Immunome files for automatic mixed securities shelf.

Tue Feb 13, 2024

Activity

immunome (imnm) to acquire desmoid tumor candidate stock up. shares of immunome inc. imnm were up 36.9% on feb 6 after the company announced that it has entered into a definitive asset purchase

Wed Feb 7, 2024

Activity
Momentum

immunome to acquire al102 al101 drug candidates from ayala pharma. (rttnews) - immunome inc. (imnm) announced on tuesday that it has signed a definitive asset purchase agreement to acquire al102 and its related drug candidate al101 from ayala ph

Tue Feb 6, 2024

Activity

immunome licenses zpc-21 and adc platform technology from zentalis. (rttnews) - immunome inc. (imnm) and zentalis pharmaceuticals inc. (zntl) have entered into an exclusive worldwide license agreement under which immunome has licensed from zenta

Mon Jan 8, 2024

Activity
Potential

immunome appoints phil roberts as chief technical officer.

Thu Jan 4, 2024

Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 13 events in the last 90 days from financial news and social media. Last updated Feb 23, 2024 13:28 Wall St. time
 
 

IMNM Total Score

 
 
 
 
 
 
 
StocksRunner

Discover IMNM Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of IMNM. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our IMNM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

IMNM Stock trends

IMNM Stock performance

IMNM Stock analysis

IMNM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker